Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) Interest Expenses (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Interest Expenses for 2 consecutive years, with $671000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses changed N/A to $671000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $671000.0 through Dec 2025, up 191.74% year-over-year, with the annual reading at $671000.0 for FY2025, 191.74% up from the prior year.
  • Interest Expenses for Q4 2025 was $671000.0 at NRX Pharmaceuticals, up from $230000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $671000.0 in Q4 2025, with the low at $230000.0 in Q1 2024.